XML 25 R78.htm IDEA: XBRL DOCUMENT v2.4.0.6
17. Peoples Bancorp of North Carolina, Inc. (Parent Company Only) Condensed Financial Statements (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Assets      
Interest-bearing time deposit $ 16,226 $ 6,704  
Investment securities available for sale 297,823 321,388  
Total assets 1,013,516 1,067,063  
Liabilities and Shareholders' Equity      
Junior subordinated debentures 20,619 20,619  
Shareholders' equity 97,747 103,027  
Total liabilities and shareholders' equity 1,013,516 1,067,063  
Revenues:      
Interest and dividend income 39,245 45,259 47,680
Other than temporary impairment losses 0 (144) (291)
Expenses:      
Interest 7,696 10,946 14,348
Loss before income tax benefit and equity in undistributed earnings of subsidiaries 7,380 6,622 1,830
Income tax benefit 1,587 1,463 (11)
Net earnings 5,793 5,159 1,841
Cash flows from operating activities:      
Net earnings 5,793 5,159 1,841
Adjustments to reconcile net earnings to net cash used by operating activities:      
Impairment of investment securities 0 (144) (291)
Change in:      
Other assets 399 (2,644) 2,316
Net cash provided (used by) operating activities 19,027 22,352 17,798
Cash flows from investing activities:      
Purchases of investment securities available for sale (88,304) (208,863) (232,915)
Proceeds from maturities of investment securities available for sale 63,225 54,041 86,935
Net change in interest-bearing time deposit 0 735 2,610
Net cash provided (used) by investing activities 64,797 (7,719) (44,024)
Cash flows from financing activities:      
Cash dividends paid on Series A preferred stock (1,023) (1,253) (1,253)
Preferred stock and warrant repurchase (12,122) 0 0
Restricted stock payout 0 17 12
Proceeds from exercise of stock options 539 0 0
Net cash (used) provided by financing activities (64,217) (9,374) 18,863
Net change in cash and cash equivalent 19,607 5,259 (7,363)
Noncash investing and financing activities:      
Change in unrealized gain on investment securities available for sale, net (2,536) 3,087 (1,838)
Parent Company
      
Assets      
Cash 324 316 425
Interest-bearing time deposit 800 15,000  
Investment in subsidiaries 115,386 106,469  
Investment securities available for sale 1,596 1,520  
Other assets 260 341  
Total assets 118,366 123,646  
Liabilities and Shareholders' Equity      
Junior subordinated debentures 20,619 20,619  
Shareholders' equity 97,747 103,027  
Total liabilities and shareholders' equity 118,366 123,646  
Revenues:      
Interest and dividend income 113 226 311
Other than temporary impairment losses 0 (144) (291)
Total revenues 113 82 20
Expenses:      
Interest 438 407 411
Other operating expenses 476 190 191
Total expenses 914 597 602
Loss before income tax benefit and equity in undistributed earnings of subsidiaries (801) (515) (582)
Income tax benefit 166 56 24
Loss before equity in undistributed earnings of subsidiaries (635) (459) (558)
Equity in undistributed earnings of subsidiaries 6,428 5,618 2,399
Net earnings 5,793 5,159 1,841
Cash flows from operating activities:      
Net earnings 5,793 5,159 1,841
Adjustments to reconcile net earnings to net cash used by operating activities:      
Equity in undistributed earnings of subsidiaries (6,428) (5,618) (2,399)
Impairment of investment securities 0 (144) (291)
Change in:      
Other assets 0 112 (66)
Accrued income 11 (11) 0
Accrued expense 41 (216) 147
Net cash provided (used by) operating activities (583) (430) (186)
Cash flows from investing activities:      
Purchases of investment securities available for sale 0 0 (36,000)
Proceeds from maturities of investment securities available for sale 0 0 36,000
Net change in interest-bearing time deposit 14,200 2,000 2,000
Net cash provided (used) by investing activities 14,200 2,000 2,000
Cash flows from financing activities:      
Cash dividends paid on Series A preferred stock (1,023) (1,253) (1,253)
Cash dividends paid on common stock (1,003) (443) (448)
Preferred stock and warrant repurchase (12,122) 0 0
Restricted stock payout 0 17 12
Proceeds from exercise of stock options 539 0 0
Net cash (used) provided by financing activities (13,609) (1,679) (1,689)
Net change in cash and cash equivalent 8 (109) 125
Cash at beginning of year 316 425 300
Cash at end of year 324 316 425
Noncash investing and financing activities:      
Change in unrealized gain on investment securities available for sale, net $ (46) $ (3) $ (172)